Protein-losing enteropathy as a new phenotype in atypical hemolytic uremic syndrome caused by CD46 gene mutation
- Published on 01/31/2025
- Reading time: 6 min.
Chunyan Wang 1 ,2 na1, Jing Chen 1 ,2 na1, Hong Xu 1 ,2 ,3
1 Department of Nephrology, Children’s Hospital of Fudan University, National Children’s Medical Center, Shanghai, 201102, China
2 Shanghai Kidney Development & Pediatric Kidney Disease Research Center, Shanghai, China
3 National Key Laboratory of Kidney Diseases, Beijing, China
Abstract
Background Atypical hemolytic uremic syndrome (aHUS) is a life-threatening thrombotic microangiopathy. Genetic defects in the alternative complement (AP) pathway have been identified in 60-70% of individuals. Eculizumab is recommended as a first-line therapy.
Methods We collected the clinical data of a pediatric patient with aHUS accompanied by protein-losing enteropathy (PLE). Genetic testing was performed. Related literature on aHUS combined with PLE...
To continue reading this article in Full-Text...
Peer-Reviewed Journals A-Z
Search | Advanced search
Get the latest news in Rare Diseases
Receive our newsletter to stay up to date with the latest news in Rare Diseases